Various Cancer Types

EAY191 / ComboMATCH

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Physician Fact Sheet

In revision.

Study Flowchart
Brief ComboMATCH description with basic eligibility criteria and a visual of the registration and treatment trial process

Patient Educational Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.

Study Summary for Patients
Study objectives, eligibility criteria, and a simplified schema in lay language to provide a more visual description of the trial to patients. All site staff are encouraged to share this as appropriate when explaining the trial to potential participants.

Recruitment/Awareness Promotional Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material. Note: this content can be utilized for site-specific and community outreach (e.g., webpages, informational handouts, posters, etc.) to encourage potential participants to talk with their doctor, or to contact a site where the study is open for more information. The content may not be modified, and the entities who implement this plan (not including clinical staff) must refrain from direct engagement with patients, except to encourage them to speak with their doctor, or to direct them to the trial page on ECOG-ACRIN or Cancer.gov.

Patient-Directed Communications Plan
Patient-friendly language, images, and sample social media posts for use by participating sites and patient advocates to promote awareness of and recruitment to this trial
ComboMATCH-gray-border-v2-reduced

ComboMATCH Home Page

View EAY191 / ComboMATCH Record on ClinicalTrials.gov
Review Other Active Trials
ECOG-ACRIN Cancer Research Group